A powerful campaigning organisation, Brain Tumour Research is the leading voice of the brain tumour community. Unique and much needed, we are the only national charity focused on finding a cure for all types of brain tumours. We are campaigning to increase the national investment in research into brain tumours to £35 million per year, while fundraising to create a network of seven sustainable Brain Tumour Research Centres of Excellence across the UK. We are seeking a Director of Finance & Operations to join our dynamic, innovative and collaborative Leadership Team at a pivotal point in our development as we seek to grow and reach and impact even further. This is a rare opportunity to lead a broad portfolio spanning finance, HR, systems, governance, risk and operational delivery, all within a charity that is rapidly growing its reach, influence and impact. In this role, you will shape organisational strategy, strengthen financial stewardship, and ensure we have the systems, processes and culture needed to support the next stage of our development. You’ll lead talented teams, embed high-performing ways of working, and play a key role in enabling world-class research and national campaigning. We’re looking for a strategic, values-led leader with a strong track record across both finance and operations. Someone who can see the bigger picture, think commercially, and bring rigour, insight and clarity to decision-making. You’ll be an empowering people manager, an excellent communicator, and a collaborative partner who thrives in a mission-driven environment. Above all, you’ll bring energy, curiosity and a genuine commitment to making a difference for people affected by brain tumours. If you’re ready to take on a wide-ranging leadership role with real purpose, and help build a stronger organisation working towards a future free from brain tumours, we’d love to hear from you. For further information and details on how to apply, please visit: www.berwickpartners.co.uk/95693 Closing date for applications: 9am on Friday 10th April 2026.